Furthermore, we found that CCDC26/miR-140-5p/GLRX5 and LINC01515/miR-425-5p/DICER1 may be potential ceRNA regulatory networks in the development and drug resistance of CML. The gene discussed is GLRX5; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.